Business - Briefly   

Aurobindo Pharma gets nod for making Lisinopril

HYDERABAD : The Medicines Control Council of South Africa has granted authorisation to Aurobindo Pharma to participate in the key segment of the medicine market by manufacturing Lisinopril tablets in 5 mg, 10 mg, and 20 mg strengths. Lisinopril is the generic version of Zestril marketed by Zeneca. The drug, used often in the management of hypertension, commands a market value of $27 million, says a release.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

First major FDI in refining
HLL net profit up 32 p.c.
Board approves name change
CGN ties up with TPI
Apollo plans to take over U.K. hospitals
Essar Global buys Bermuda-based BPO co.
Indian Bank opens branch in Dharavi slum
Sensex sheds 150 points
Rupee posts further losses
Exchange rates
Bullion rates
DLF fined Rs. 1 cr. for trading in BFSL
Flexibility to ULIPs investment plans
Ranbaxy to submit bid for Merck (generics)
AETL gets process patent
Sony Pictures picks up equity in FrameFlow
Maveric Systems ties up with U.K. consultant
IndiGo announces promotional offer
Nexxoft acquires eZeesoft
Bentley gets DCGI nod for Nasulin Phase II trial
Aurobindo Pharma gets nod for making Lisinopril
Andhra Bank to get `mobile' ATMs

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu